Studieoverzicht

 
 
  2018-03 TRAIN-3       Submitted (METC)       Neoadjuvant       HER2+, any HR       Not applicable  
  2017-01 NEOLBC       Open       Neoadjuvant       HER2- HR+       Postmenopausal  
  2013-04 DIRECT       Follow up       Neoadjuvant       HER2-, any HR       Both pre- and postmenopausal  
  2012-03 TRAIN-2       Follow up       Neoadjuvant       HER2+, any HR       Both pre- and postmenopausal  
  2010-01 NEO-ZOTAC       Follow up       Neoadjuvant       HER2-, any HR       Both pre- and postmenopausal  
  2007-02 INTENS       Closed       Neoadjuvant       Any HER2, any HR       Both pre- and postmenopausal  
  2006-04a TEAM IIa       Closed       Neoadjuvant       Any HER2, HR+       Postmenopausal